ACTU Next Earnings Date Notes

— Actuate Therapeutics, Inc. (ACTU) is a clinical-stage biotechnology company focused on developing therapies for cancer and inflammatory diseases, with a lead candidate, elraglusib (formerly 9-ING-41), targeting GSK-3b2 to disrupt critical signaling pathways in oncology & neurodegeneration. As you get ready for the next ACTU earnings call, jot down that the company's long-term success will hinge less on near-term revenue and more on clinical trial progress, partnerships, regulatory milestones, and cash runway. Key metrics to follow include updates on enrollment/completion of pivotal trials, especially for elraglusib in glioblastoma & other indications; safety & efficacy data; and any guidance around anticipated filings with the FDA or EMA. Also, watch for disclosures about collaborations, licensing deals, or funding events, as these directly impact ACTU’s ability to advance its pipeline. The company’s quarterly burn rate vs. available cash is crucial, since biotech valuations depend on having enough capital to reach value-inflection points. Management's discussion of milestones and strategic priorities in the call commentary will help gauge the pace and robustness of pipeline advancement—and, ultimately, investor value creation. The next projected earnings date for ACTU is 8/13/2026 after close (stay tuned for a confirmed earnings date once announced).

ACTU Next Earnings Date FAQ

On this page we presented the ACTU Next Earnings Date information for Actuate Therapeutics along with recent past earnings dates. For Q1 of 2026, ACTU reported earnings of -0.240/share, with the earnings report taking place on 5/14/2026. For Q4 of 2025, ACTU reported earnings of /share, with the earnings report taking place on 4/21/2026. For Q4 of 2025, ACTU reported earnings of -0.180/share, with the earnings report taking place on 3/26/2026. For Q3 of 2025, ACTU reported earnings of -0.250/share, with the earnings report taking place on 11/13/2025. For Q2 of 2025, ACTU reported earnings of /share, with the earnings report taking place on 9/23/2025. Based on these past earnings dates, the projected next earnings date for ACTU is 8/13/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Actuate Therapeutics. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Actuate Therapeutics shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Actuate Therapeutics next earnings dates as well as any other stock out there in our coverage universe, to see when the next ACTU earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up ACTU's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the ACTU next earnings date.